SPARC is highly expressed in obesity and type 2 diabetes mellitus (T2DM), and levels of SPARC in plasma are relatively high in T2DM patients (Wu et al., 2011). Here, SPARC is linked to obesity due to melanocortin 4 receptor deficiency.